| BE0396-100MG
| InVivoMAb anti-human/mouse GRP78
| 100 mg
| BioXCell
| in vivo GRP78 blockade, in vitro GRP78 blockade, W
|
| Mouse
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BP0115-25MG
| InVivoPlus anti-mouse TIM-3 (CD366)
| 25 mg
| BioXCell
| in vivo TIM-3 neutralization, in vitro TIM-3 block
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0099-5MG
| InVivoPlus recombinant CTLA-4-Ig (hum/hum)
| 5 mg
| BioXCell
|
|
|
|
| Solicitar Precio
| Solicitar
|
| BP0329-5MG
| InVivoPlus anti-mouse CD71 (TfR1)
| 5 mg
| BioXCell
| in vivo depletion of CD71+ cells, Immunofluorescen
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0085-25MG
| InVivoPlus mouse IgG2a isotype control, unknown specificity
| 25 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BP0174-50MG
| InVivoPlus anti-mouse LAG-3
| 50 mg
| BioXCell
| in vivo LAG-3 neutralization, in vitro LAG-3 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0390-25MG
| InVivoMAb anti-canine PD-L1 (B7-H1)
| 25 mg
| BioXCell
| in vitro PD-L1 blockade, Functional assays, Wester
|
| Dog
| Dog
| Solicitar Precio
| Solicitar
|
| BE0379-100MG
| InVivoMAb anti-mouse TSLP
| 100 mg
| BioXCell
| in vivo TSLP neutralization, in vitro TSLP neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0394-50MG
| InVivoMAb anti-mouse IL-25
| 50 mg
| BioXCell
| in vivo IL-25 neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0099-25MG
| InVivoPlus recombinant CTLA-4-Ig (hum/hum)
| 25 mg
| BioXCell
|
|
|
|
| Solicitar Precio
| Solicitar
|
| BP0115-50MG
| InVivoPlus anti-mouse TIM-3 (CD366)
| 50 mg
| BioXCell
| in vivo TIM-3 neutralization, in vitro TIM-3 block
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0003-3-5MG
| InVivoPlus anti-mouse CD4
| 5 mg
| BioXCell
| in vivo blockade of CD4+ T-cell responses, Western
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0051-50MG
| InVivoPlus anti-mouse IL-12 p40
| 50 mg
| BioXCell
| in vivo IL-12p40 neutralization, p40 affinity chro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0383-1MG
| InVivoMAb anti-mouse/human/rat PD-L1
| 1 mg
| BioXCell
| in vivo PD-L1 blockade
, in vitro PD-L1 blockade
,
|
| Mouse/Human/Rat
|
| Solicitar Precio
| Solicitar
|
| BP0131-25MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 25 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Syrian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0407-5MG
| InVivoMAb anti-human Fy3
| 5 mg
| BioXCell
| , ,
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BP0274-100MG
| InVivoPlus anti-mouse TIGIT
| 100 mg
| BioXCell
| in vivo TIGIT stimulation, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0075-1-5MG
| InVivoPlus anti-mouse Ly6G
| 5 mg
| BioXCell
| in vivo neutrophil depletion, in vivo MDSC depleti
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0389-25MG
| InVivoMAb anti-canine CD34
| 25 mg
| BioXCell
| Immunohistochemistry (frozen), Flow cytometry, Wes
|
| Mouse
| Dog
| Solicitar Precio
| Solicitar
|
| BE0381-50MG
| InVivoMAb anti-human GM-CSF
| 50 mg
| BioXCell
| Immunofluorescence, ELISA, Flow cytometry
|
| Rat
| Human
| Solicitar Precio
| Solicitar
|
| BP0173-100MG
| InVivoPlus anti-mouse IL-17A
| 100 mg
| BioXCell
| in vivo IL-17A neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0089-50MG
| InVivoPlus rat IgG2a isotype control, anti-trinitrophenol
| 50 mg
| BioXCell
|
|
| Rat
|
| Solicitar Precio
| Solicitar
|
| BE0386-5MG
| InVivoMAb anti-human CD326 (EpCAM)
| 5 mg
| BioXCell
| Immunohistochemistry (paraffin), Immunofluorescenc
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0389-1MG
| InVivoMAb anti-canine CD34
| 1 mg
| BioXCell
| Immunohistochemistry (frozen), Flow cytometry, Wes
|
| Mouse
| Dog
| Solicitar Precio
| Solicitar
|
| BE0381-100MG
| InVivoMAb anti-human GM-CSF
| 100 mg
| BioXCell
| Immunofluorescence, ELISA, Flow cytometry
|
| Rat
| Human
| Solicitar Precio
| Solicitar
|
| BE0390-100MG
| InVivoMAb anti-canine PD-L1 (B7-H1)
| 100 mg
| BioXCell
| in vitro PD-L1 blockade, Functional assays, Wester
|
| Dog
| Dog
| Solicitar Precio
| Solicitar
|
| BE0399-1MG
| InVivoMAb anti-mouse VEGF-A
| 1 mg
| BioXCell
| in vivo VEGF-A neutralization, Western blot,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0387-5MG
| InVivoMAb anti-mouse/human phosphorylated PD-1 (CD279)
| 5 mg
| BioXCell
| Western Blot, Flow Cytometry
|
| Mouse
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0401-1MG
| InVivoMAb anti-human CEACAM5
| 1 mg
| BioXCell
| , ,
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BE0408-50MG
| InVivoMAb anti-human TROP-2
| 50 mg
| BioXCell
| Western blot, Immunohistochemistry (frozen), Flow
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BP0099-50MG
| InVivoPlus recombinant CTLA-4-Ig (hum/hum)
| 50 mg
| BioXCell
|
|
|
|
| Solicitar Precio
| Solicitar
|
| BE0400-50MG
| InVivoMAb anti-mouse RGMb
| 50 mg
| BioXCell
| in vivo RGMb blockade, ELISA, Flow cytometry, ,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0395-50MG
| InVivoMAb anti-mouse/human Mac-2 (Galectin-3)
| 50 mg
| BioXCell
| Western blot, Immunofluorescence, Immunohistochemi
|
| Rat
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0400-1MG
| InVivoMAb anti-mouse RGMb
| 1 mg
| BioXCell
| in vivo RGMb blockade, ELISA, Flow cytometry, ,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0406-5MG
| InVivoMAb anti-human CD2
| 5 mg
| BioXCell
| , ,
|
| Rat
|
| Solicitar Precio
| Solicitar
|
| BE0413-5MG
| InVivoMAb anti-rat TCR ?/?
| 5 mg
| BioXCell
| in vivo administration
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BP0301-25MG
| InVivoPlus human IgG2 isotype control
| 25 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
| BE0391-50MG
| InVivoMAb anti-human MUC16
| 50 mg
| BioXCell
| Flow cytometry, Western blot
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0075-1-50MG
| InVivoPlus anti-mouse Ly6G
| 50 mg
| BioXCell
| in vivo neutrophil depletion, in vivo MDSC depleti
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0175-100MG
| InVivoPlus anti-mouse CD71 (TfR1)
| 100 mg
| BioXCell
| in vivo depletion of CD71+ cells
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0164-100MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 100 mg
| BioXCell
| in vivo CTLA-4 neutralization, Western blot
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0063-50MG
| InVivoPlus anti-mouse GITR
| 50 mg
| BioXCell
| in vivo GITR stimulation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0388-1MG
| InVivoMAb anti-human CD71 (TfR1)
| 1 mg
| BioXCell
| Immunohistochemistry (frozen)
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0382-5MG
| InVivoMAb anti-mouse/human/rat osteopontin (SPP1)
| 5 mg
| BioXCell
| in vivo OPN neutralization, in vitro OPN neutraliz
|
| Mouse
| Human, Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BP0079-100MG
| InVivoPlus anti-human MHC Class I (HLA-A, HLA-B, HLA-C)
| 100 mg
| BioXCell
| Functional assays
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BP0055-50MG
| InVivoPlus anti-mouse IFN?
| 50 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0383-25MG
| InVivoMAb anti-mouse/human/rat PD-L1
| 25 mg
| BioXCell
| in vivo PD-L1 blockade
, in vitro PD-L1 blockade
,
|
| Mouse/Human/Rat
|
| Solicitar Precio
| Solicitar
|
| BE0384-50MG
| InVivoMAb anti-human GM-CSF
| 50 mg
| BioXCell
| in vitro GM-CSF neutralization, ELISA
|
| Rat
| Human
| Solicitar Precio
| Solicitar
|
| BE0382-50MG
| InVivoMAb anti-mouse/human/rat osteopontin (SPP1)
| 50 mg
| BioXCell
| in vivo OPN neutralization, in vitro OPN neutraliz
|
| Mouse
| Human, Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BE0413-100MG
| InVivoMAb anti-rat TCR ?/?
| 100 mg
| BioXCell
| in vivo administration
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|